Altered Brain Energy Metabolism Related to Astrocytes in Alzheimer's Disease

  • Kosei Hirata
    Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
  • Kiwamu Matsuoka
    Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
  • Kenji Tagai
    Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
  • Hironobu Endo
    Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
  • Harutsugu Tatebe
    Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
  • Maiko Ono
    Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
  • Naomi Kokubo
    Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
  • Asaka Oyama
    Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
  • Hitoshi Shinotoh
    Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
  • Keisuke Takahata
    Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
  • Takayuki Obata
    Department of Molecular Imaging and Theranostics, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
  • Masoumeh Dehghani
    Physical Sciences, Sunnybrook Research Institute Toronto Canada
  • Jamie Near
    Physical Sciences, Sunnybrook Research Institute Toronto Canada
  • Kazunori Kawamura
    Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
  • Ming‐Rong Zhang
    Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
  • Hitoshi Shimada
    Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
  • Takanori Yokota
    Department of Neurology and Neurological Science Tokyo Medical and Dental University Tokyo Japan
  • Takahiko Tokuda
    Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
  • Makoto Higuchi
    Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan
  • Yuhei Takado
    Department of Functional Brain Imaging, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology Chiba Japan

この論文をさがす

説明

<jats:sec><jats:title>Objective</jats:title><jats:p>Increasing evidence suggests that reactive astrocytes are associated with Alzheimer's disease (AD). However, its underlying pathogenesis remains unknown. Given the role of astrocytes in energy metabolism, reactive astrocytes may contribute to altered brain energy metabolism. Astrocytes are primarily considered glycolytic cells, suggesting a preference for lactate production. This study aimed to examine alterations in astrocytic activities and their association with brain lactate levels in AD.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>The study included 30 AD and 30 cognitively unimpaired participants. For AD participants, amyloid and tau depositions were confirmed by positron emission tomography using [<jats:sup>11</jats:sup>C]PiB and [<jats:sup>18</jats:sup>F]florzolotau, respectively. Myo‐inositol, an astroglial marker, and lactate in the posterior cingulate cortex were quantified by magnetic resonance spectroscopy. These magnetic resonance spectroscopy metabolites were compared with plasma biomarkers, including glial fibrillary acidic protein as another astrocytic marker, and amyloid and tau positron emission tomography.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Myo‐inositol and lactate levels were higher in AD patients than in cognitively unimpaired participants (<jats:italic>p</jats:italic> < 0.05). Myo‐inositol levels correlated with lactate levels (<jats:italic>r</jats:italic> = 0.272, <jats:italic>p</jats:italic> = 0.047). Myo‐inositol and lactate levels were positively associated with the Clinical Dementia Rating sum‐of‐boxes scores (<jats:italic>p</jats:italic> < 0.05). Significant correlations were noted between myo‐inositol levels and plasma glial fibrillary acidic protein, tau phosphorylated at threonine 181 levels, and amyloid and tau positron emission tomography accumulation in the posterior cingulate cortex (<jats:italic>p</jats:italic> < 0.05).</jats:p></jats:sec><jats:sec><jats:title>Interpretation</jats:title><jats:p>We found high myo‐inositol levels accompanied by increased lactate levels in the posterior cingulate cortex in AD patients, indicating a link between reactive astrocytes and altered brain energy metabolism. Myo‐inositol and plasma glial fibrillary acidic protein may reflect similar astrocytic changes as biomarkers of AD. ANN NEUROL 2024;95:104–115</jats:p></jats:sec>

収録刊行物

参考文献 (59)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ